Template:Mastitis antibiotics: Difference between revisions

No edit summary
Line 5: Line 5:


===[[Antibiotics]]===
===[[Antibiotics]]===
''Treatment directed at S. aureus and Strep and E. coli''
''Treatment directed at [[S. aureus]] and [[Strep]] and [[E. coli]]''
*Uncomplicated mastitis → 10 days of Abx (regardless of MRSA suspicion)<ref>Levine BL. 2011 EMRA Antibiotic Guide. EMRA. Pg 78.</ref>
*Uncomplicated mastitis → 10 days of antibiotics (regardless of [[MRSA]] suspicion)<ref>Levine BL. 2011 EMRA Antibiotic Guide. EMRA. Pg 78.</ref>
*[[Cephalexin]] 500mg PO q6hrs '''OR'''
*[[Cephalexin]] 500mg PO q6hrs '''OR'''
**Add [[TMP/SMX]] 2DS tabs PO q12hrs if suspect [[MRSA]]
**Add [[TMP/SMX]] 2DS tabs PO q12hrs if suspect [[MRSA]]

Revision as of 21:11, 3 April 2017

  • No need to routinely interrupt breastfeeding with puerperal mastitis.
  • For mild symptoms <24 hours, supportive care may be sufficient[1]
    • Effective milk removal (frequent breast feeding - use pumping to augment milk removal)
    • Analgesia (NSAIDs)

Antibiotics

Treatment directed at S. aureus and Strep and E. coli

  1. Amir LH. ABM Clinical Protocol #4: Mastitis, Revised March 2014. Breastfeeding Medicine. 2014;9(5):239-243. doi:10.1089/bfm.2014.9984.
  2. Levine BL. 2011 EMRA Antibiotic Guide. EMRA. Pg 78.